Search for: "Watson Pharmaceuticals Inc." Results 121 - 140 of 224
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
17 Jul 2011, 9:17 pm by Patent Docs
Watson Pharmaceuticals et al. 1:11-cv-00607; filed July 8, 2011 in the District Court of Delaware • Plaintiffs: Abbott Laboratories; Abbott Respiratory LLC • Defendants: Watson Pharmaceuticals Inc.; Watson Laboratories Inc. [read post]
10 Jul 2011, 9:20 pm by Patent Docs
• Defendants: Watson Pharmaceuticals, Inc.; Watson Laboratories, Inc.; Watson Laboratories, Inc. [read post]
8 Jul 2011, 1:13 pm by Phil
The following is excerpted from a July 7, 2011 Watson press release published at PR Newswire: Watson Pharmaceuticals, Inc. [read post]
4 Jul 2011, 9:59 pm by Patent Docs
• Defendants: Watson Laboratories Inc.; Watson Pharmaceuticals Inc.; Watson Pharma Inc. [read post]
In addition, following the submission of one of the proposals (to Watson Pharmaceuticals, Inc.), the company announced a plan to bring a declassification proposal to a vote at its 2011 annual meeting. [read post]
22 Jun 2011, 4:09 am by Marie Louise
A-G’s opinion published – Merck & Co Inc. v Deutsches Patent- und Markenamt (EPLAW) (The SPC Blog) US: Supreme Court to revisit patentable subject matter eligibility of medical diagnostic methods:  Mayo v Prometheus (Patently-O) (Patent Baristas) (PharmaPatents) (IPBiz) (Patent Law Practice Center) US: Intellectual property problems for personalized medicine (BIOtechNow) US: Supreme Court ruling in Stanford v Roche (IPKat) (IPKat) US: Manager’s Amendment (and… [read post]
9 Jun 2011, 10:16 am
Indianapolis, IN - Patent lawyers for Alcon Research Ltd of Fort Worth, Texas, Alcon Pharmaceuticals LTD of Switzerland, and Kyowa Haddo Kirin Co. of Japan filed a patent infringement in alleging Watson Laboratories Inc and Watson Pharma, Inc. of Parsippany, New Jersey, and Watson Laboratories, of Corona, California, infringed the following patent prior to the expiration: Patent No. 5,641,805, Topical ophthalmic formulations for treating allergic… [read post]
15 May 2011, 2:54 pm by FDABlog HPM
LLC, Watson Pharmaceuticals, Inc., and Synthon Holding B.V. notifying them that the Bureau believes the companies violated federal law by failing to inform antitrust authorities about patent agreements involving Sanofi’s insomnia drug AMBIEN CR (zolpidem tartrate) Tablets, but that instead of recommending that the FTC take enforcement action, it would issue advisory letters. [read post]
10 May 2011, 4:24 pm by Aaron Barkoff
LLC, Watson Pharmaceuticals, Inc., and Synthon Holding B.V., that it believes the companies violated federal law by failing to inform antitrust authorities about drug patent agreements involving Sanofi's insomnia drug Ambien CR. [read post]
8 May 2011, 11:58 am by Law Lady
Watson Pharms., 8 No. 5 Westlaw Journal Expert and Scientific Evidence 10, Westlaw Journal Expert and Scientific Evidence April 20, 2011A California judge has ordered Watson Pharmaceuticals to turn over key documents and other data about a pain patch that allegedly caused a user to overdose on fentanyl. [read post]
4 May 2011, 7:52 am by Tron Emptage
  Generic Opioid Products Generic Name Drug Name Applicant/Sponsors Fentanyl Fentanyl Extended Release Transdermal System Actavis   Fentanyl Fentanyl Extended Release Transdermal System Lavipharm Labs   Fentanyl Fentanyl Extended Release Transdermal System Mylan Technologies   Fentanyl Fentanyl Extended Release Transdermal System Teva Pharms   Fentanyl Fentanyl Extended Release Transdermal System Watson   … [read post]
In addition, following the submission of one of the Foundation’s proposals (to Watson Pharmaceuticals, Inc.), the company announced a plan to bring a declassification proposal to a vote at its 2011 annual meeting. [read post]
1 May 2011, 8:45 pm by Patent Docs
• Defendants: Watson Pharmaceuticals Inc.; Watson Pharma Inc.; Watson Laboratories Inc. [read post]